Last Updated: May 6, 2026

NICARDIPINE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Nicardipine, and when can generic versions of Nicardipine launch?

Nicardipine is a drug marketed by Amneal, Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Navinta Llc, Pharmobedient, Senores Pharms, Am Regent, Chengdu Shuode, Eugia Pharma, Hikma, Hikma Intl Pharms, Mankind Pharma, Micro Labs, Nanjing King Friend, Qilu Pharm Hainan, Somerset Theraps Llc, Sun Pharm, Inforlife, Caplin, and Cipla. and is included in twenty-six NDAs.

The generic ingredient in NICARDIPINE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nicardipine

A generic version of NICARDIPINE was approved as nicardipine hydrochloride by ANI PHARMS on October 28^th, 1996.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for NICARDIPINE?
What are the global sales for NICARDIPINE?
What is Average Wholesale Price for NICARDIPINE?

Summary for NICARDIPINE

US Patents:	0
Applicants:	22
NDAs:	26
Drug Prices:	Drug price information for NICARDIPINE
DailyMed Link:	NICARDIPINE at DailyMed

Drug patent expirations by year for NICARDIPINE

US Patents and Regulatory Information for NICARDIPINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Intl Pharms	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	022276-003	Apr 7, 2016	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Somerset Theraps Llc	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	090664-001	Nov 17, 2009	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Micro Labs	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	216420-001	Jul 7, 2023	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Sun Pharm	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	078405-001	Nov 17, 2009		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Nanjing King Friend	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	216819-001	Aug 20, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for NICARDIPINE

Are there patents for ready to use nicardipine?
Has nicardipine patent application been approved?
What is the patent status for nicardipine s new formulations?
Are nicardipine patent applications currently pending?
Are new nicardipine patents being sought?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.